Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast? SJ Kent, DS Khoury, A Reynaldi, JA Juno, AK Wheatley, E Stadler, ... Nature Reviews Immunology 22 (6), 387-397, 2022 | 110 | 2022 |
The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants M Koutsakos, WS Lee, A Reynaldi, HX Tan, G Gare, P Kinsella, KC Liew, ... Immunity 55 (7), 1316-1326. e4, 2022 | 42 | 2022 |
Determinants of passive antibody efficacy in SARS-CoV-2 infection E Stadler, KL Chai, TE Schlub, D Cromer, MN Polizzotto, SJ Kent, ... medrxiv, 2022.03. 21.22272672, 2022 | 31 | 2022 |
Monoclonal antibody levels and protection from COVID-19 E Stadler, MT Burgess, TE Schlub, SR Khan, KL Chai, ZK McQuilten, ... Nature Communications 14 (1), 4545, 2023 | 16 | 2023 |
Hypnozoite dynamics for Plasmodium vivax malaria: the epidemiological effects of radical cure S Mehra, E Stadler, D Khoury, JM McCaw, JA Flegg Journal of Theoretical Biology 537, 111014, 2022 | 13 | 2022 |
Evolutionary Stability of Salmonella Competition with the Gut Microbiota: How the Environment Fosters Heterogeneity in Exploitative and Interference Competition J Müller, S Spriewald, B Stecher, E Stadler, TM Fuchs Journal of molecular biology, 2019 | 11 | 2019 |
Eigensolutions and spectral analysis of a model for vertical gene transfer of plasmids E Stadler Journal of Mathematical Biology 78 (5), 1299-1330, 2019 | 9 | 2019 |
Evolutionary Stabilization of Cooperative Toxin Production through a Bacterium-Plasmid-Phage Interplay S Spriewald, E Stadler, BA Hense, PC Münch, AC McHardye, AS Weiss, ... mBio 11, e00912-20, 2020 | 8 | 2020 |
Viral clearance as a surrogate of clinical efficacy for COVID-19 therapies in outpatients: a systematic review and meta-analysis KM Elias, SR Khan, E Stadler, TE Schlub, D Cromer, MN Polizzotto, ... The Lancet Microbe, 2024 | 6 | 2024 |
Population heterogeneity in Plasmodium vivax relapse risk E Stadler, D Cromer, S Mehra, AI Adekunle, JA Flegg, NM Anstey, ... PLoS neglected tropical diseases 16 (12), e0010990, 2022 | 6 | 2022 |
Plasmid segregation and accumulation J Müller, K Münch, B Koopmann, E Stadler, L Roselius, D Jahn, R Münch arXiv preprint arXiv:1701.03448, 2017 | 5 | 2017 |
Determinants of passive antibody efficacy in SARS-CoV-2 infection: a systematic review and meta-analysis E Stadler, KL Chai, TE Schlub, D Cromer, SR Khan, MN Polizzotto, ... The Lancet Microbe 4 (11), e883-e892, 2023 | 4 | 2023 |
Analyzing plasmid segregation: existence and stability of the eigensolution in a non-compact case E Stadler, J Müller Discrete & Continuous Dynamical Systems-B, 2020 | 4 | 2020 |
Dynamics of immune recall following SARS-CoV-2 vaccination or breakthrough infection M Koutsakos, WS Lee, A Reynaldi, HX Tan, G Gare, P Kinsella, KC Liew, ... medRxiv, 2021.12. 23.21268285, 2021 | 3 | 2021 |
Propensity of selecting mutant parasites for the antimalarial drug cabamiquine E Stadler, M Maiga, L Friedrich, V Thathy, C Demarta-Gatsi, A Dara, ... Nature communications 14 (1), 5205, 2023 | 2 | 2023 |
Evidence for exposure dependent carriage of malaria parasites across the dry season: modelling analysis of longitudinal data E Stadler, D Cromer, S Ogunlade, A Ongoiba, S Doumbo, K Kayentao, ... Malaria Journal 22 (1), 42, 2023 | 2 | 2023 |
Risk of Plasmodium vivax recurrences follows a 30-70 rule and indicates relapse heterogeneity in the population E Stadler, D Cromer, S Mehra, AI Adekunle, JA Flegg, NM Anstey, ... medRxiv, 2022.05. 18.22275180, 2022 | 1 | 2022 |
A role for super-spreaders in carrying malaria parasites across the months-long dry season E Stadler, D Cromer, S Ogunlade, A Ongoiba, S Doumbo, K Kayentao, ... medRxiv, 2022.04. 28.22274398, 2022 | | 2022 |
Determinants of passive antibody efficacy in SARS-CoV-2 infection (preprint) E Stadler, KL Chai, T Schlub, D Cromer, M Polizzotto, S Kent, C Beecher, ... | | 2022 |
Monoclonal antibody levels and protection from COVID-19 (preprint) E Stadler, MT Burgess, TE Schlub, KL Chai, ZK McQuilten, EM Wood, ... | | 2022 |